The surgical robotics company's procedure growth remained impressive, supporting recurring revenue. Intuitive Surgical's Da Vinci 5 adoption is ramping quickly. Sales of Ion are growing faster than ...

On Tuesday, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories. The ...

SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that ...

Intuitive Surgical, Inc. ISRG is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on ...

Intuitive Surgical’s ISRG third-quarter performance highlights a pivotal shift in its platform mix, with robotic bronchoscopy, formerly a peripheral initiative, rapidly emerging as a core growth ...

Intuitive reported a strong 2025 with total procedures up about 19% (da Vinci +18%, SP +87%, Ion +51%), placed 1,721 da Vinci systems including 870 da Vinci 5 units, and treated over 3.1 million ...

Intuitive Surgical stock was relatively flat Friday, reversing a late-Thursday pop, after the robotics giant easily beat profit views.

Intuitive Surgical's share price surged after the company reported 25% YoY revenue growth in the fourth quarter. Despite macro headwinds, robust procedure volumes, international expansion and new ...